Clinical Oncology/Epidemiology

Trial of isotretinoin and calcitriol monitored by CA 125 in patients with ovarian cancer

British Journal of Cancer volume 74, pages1479–1481(1996)Cite this article

Abstract

Twenty-two asymptomatic women with rising CA 125 levels after chemotherapy for ovarian cancer were entered into a trial of isotretinoin combined with calcitriol. Tumours were evaluated according to precise criteria based on serial CA 125 levels and by comparing regression slopes of CA 125 before and during therapy. There was no evidence based on CA 125 of any responses or significant change in tumour growth rate.

Author information

Affiliations

  1. Department of Medical Oncology, Mount Vernon Centre for Cancer Treatment, Mount Vernon Hospital, Northwood, Middlesex, UK

    GJS Rustin

Authors
  1. GJS Rustin
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. TG Quinnell
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J Johnson
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. H Clarke
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. AE Nelstrop
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. W Bollag
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Rustin, G., Quinnell, T., Johnson, J. et al. Trial of isotretinoin and calcitriol monitored by CA 125 in patients with ovarian cancer. Br J Cancer 74, 1479–1481 (1996). https://doi.org/10.1038/bjc.1996.568

Download citation

Further reading

Search

Quick links